The Opportunities and Challenges of Rethinking Our Approach to Value Assessment in Healthcare As America’s healthcare system continues to evolve, it is critical that our perception of care and its ...

Coverage and reimbursement decisions are hardly predictable or consistent within and across US payers. Payers are in the position of determining which drugs to pay for, for whom, and at what level to ...

A study published in Pharmacoeconomics and Policy provides one of the first empirical tests of a structured multi-criteria decision analysis (MCDA) framework to evaluate OMPs within the context of ...

Impact of High-Quality Goals-of-Care Discussions on Oncologist Productivity The framework was developed following Evidence and Value: Impact on Decision-Making methodology, and literature was reviewed ...